Cerebral Microbleeds Detected Using 3.0T Magnetic Resonance Imaging in 2,003 Patients with Ischemic or Hemorrhagic

Tetsuya Abe1,2, Masaki Takao1,3, Hiroaki Kimura3

  • 1Department of Neurology, Saitama Medical University International Medical Center, Hidaka, Japan.

JMA Journal
|February 22, 2021
PubMed
Abstract

Insights

Cerebral microbleeds (CMBs) are common in stroke patients, particularly those with hypertension and a history of stroke. 3.0T MRI effectively detects CMBs, which are linked to cognitive impairment.

Area of Science:

  • Neurology
  • Radiology
  • Stroke Research

Background:

  • 3.0T MRI enhances detection of cerebral microbleeds (CMBs) compared to 1.5T MRI.
  • Cerebral microbleeds are associated with various stroke types and risk factors.

Purpose of the Study:

  • To investigate the prevalence, characteristics, and risk factors of CMBs in patients with ischemic or hemorrhagic stroke using 3.0T MRI.
  • To analyze the number and location of CMBs in relation to stroke type and patient history.

Main Methods:

  • Retrospective analysis of clinical data from 2,003 stroke patients treated between January 2010 and December 2014.
  • Multivariate analysis to identify risk factors and associations with CMBs.

Main Results:

  • CMBs were detected in 1,025 patients (51.2%).
  • Significant associations found between CMBs and cognitive impairment, hypertension, prior stroke history, and hemorrhagic stroke.
  • Patients with small vessel occlusion had a higher incidence of CMBs and prior hemorrhagic stroke history compared to cardioembolic stroke patients.

Conclusions:

  • Hypertension is a key factor in both ischemic and hemorrhagic strokes with CMBs.
  • CMBs are prevalent in small vessel disease, and antithrombotic medication use does not impact CMB development with adequate antihypertensive therapy.